Overview
Status
Active
Registry date
2008-09-01
Share capital
720,000.00 PLN
Registered address
ul. Wincentego Rzymowskiego 31, 02-697 Warszawa, Poland
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 113 days early. All were audited by a statutory auditor.
- 202512/03/2026
- 202410/07/2025
- 202314/03/2024
- 202224/05/2023
- 202122/02/2022
- 202002/03/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 22.49mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 1.07mMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 20.46mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 9.11mMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Michał Andrzej Buras – Attorney-in-fact (sole)
David Caballero Tomas – Management Board Member
Maria Mar Nogareda Estivill – Management Board Member
Manner of representation
Each member of the management board is authorised to make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Laboratorios Hipra S.a | 14,400 | $194,489.47 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-02-01.
59 1600 1127 1830 4215 8000 0001
91 1600 1127 1830 4215 8000 0007
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Glenmark Pharmaceuticalssp. z o.o. | $26,934,644.29 | glenmarkpharma.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| New Approachsp. z o.o. | $22,884,976.86 | newapproach.pl | ||
| Coopervision Polandsp. z o.o. | $22,928,420.47 | coopervision.pl | ||
| Aristo Pharmasp. z o.o. | $22,775,627.72 | aristo-pharma.pl | ||
| Antar Medicalsp. z o.o. | $21,453,293.22 | antar.net | ||
| Biocodex Polskasp. z o.o. | $21,443,490.38 | biocodex.pl | ||
| Bionorica Polskasp. z o.o. | $19,802,926.77 | bionorica.pl | ||
| Dentsply Sirona Polandsp. z o.o. | $20,045,943.57 | dentsplysirona.com | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-04-10 | Address change (Ul. Przemysława Gintrowskiego 31, 02-697, Warszawa → Ul. Wincentego Rzymowskiego 31, 02-697, Warszawa) | |
| 2018-09-07 | Address change (Królowej Marysieńki 9/1, 02-954, Warszawa → Ul. Przemysława Gintrowskiego 31, 02-697, Warszawa) | |
| 2015-03-13 | PKD change (Removed: 75.00.Z) | |
| 2009-06-23 | Share capital increase (200,000.00 PLN → 720,000.00 PLN) | |
| 2009-03-03 | Address change (Kruczkowskiego 8, 00-380, Warszawa → Królowej Marysieńki 9/1, 02-954, Warszawa) |
FAQ
The main business activity of Hipra Polska focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 1, 2008.
The headquarters is located at: ul. Wincentego Rzymowskiego 31, 02-697 Warszawa.
The share capital of the company is PLN 720,000 (approx. $194,489).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 22,487,622 in 2025, which is an increase of 20.4% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 1,072,448, meaning the company increased its profit by 50.6%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 16,614,900 in 2025, representing 81% of all operating expenses.
Last updated: 2026-10-28